Tag Archives: First

Adaptive Biotechnologies stock tumbles after first earnings report since IPO

Chad Robins, CEO of Adaptive Biotechnologies. Anjali Sundaram | CNBC Adaptive Biotechnologies shares fell by more than 10% in after-hours trading Tuesday after the biotech company posted a wider-than-expected loss in its first earnings report since going public. The company posted a loss of $ 1.23 a share, down from a loss of $ 1.01… Read More »

U.S. brings first criminal case against major drug distributor over opioids

NEW YORK (Reuters) – The U.S. government on Tuesday filed its first criminal charges against a major drug distributor and company executives over their alleged roles in fueling the nation’s opioid epidemic by putting profits ahead of patients’ safety. FILE PHOTO: A general view of the Department of Justice building is seen ahead of the… Read More »